readthroughSign in
CompanyNEUPNasdaqBurlington, MA

Neuphoria Therapeutics Inc.

Scancell Holdings plc develops targeted, off-the-shelf active immunotherapies using ImmunoBody and Moditope platforms to stimulate anti-tumor responses.

10-QNov 16Latest SEC filing
Oct 23Latest story